Ardent Health Statistics
Total Valuation
Ardent Health has a market cap or net worth of $1.56 billion. The enterprise value is $3.25 billion.
| Market Cap | 1.56B |
| Enterprise Value | 3.25B |
Important Dates
The next confirmed earnings date is Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ardent Health has 143.35 million shares outstanding. The number of shares has increased by 3.91% in one year.
| Current Share Class | 143.35M |
| Shares Outstanding | 143.35M |
| Shares Change (YoY) | +3.91% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 1.65% |
| Owned by Institutions (%) | 21.04% |
| Float | 54.40M |
Valuation Ratios
The trailing PE ratio is 11.48 and the forward PE ratio is 9.96. Ardent Health's PEG ratio is 2.49.
| PE Ratio | 11.48 |
| Forward PE | 9.96 |
| PS Ratio | 0.24 |
| Forward PS | 0.24 |
| PB Ratio | 1.17 |
| P/TBV Ratio | 4.24 |
| P/FCF Ratio | 7.19 |
| P/OCF Ratio | 3.60 |
| PEG Ratio | 2.49 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.47, with an EV/FCF ratio of 14.89.
| EV / Earnings | 24.17 |
| EV / Sales | 0.50 |
| EV / EBITDA | 6.47 |
| EV / EBIT | 9.56 |
| EV / FCF | 14.89 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 1.32.
| Current Ratio | 2.12 |
| Quick Ratio | 1.40 |
| Debt / Equity | 1.32 |
| Debt / EBITDA | 4.56 |
| Debt / FCF | 10.51 |
| Interest Coverage | 6.38 |
Financial Efficiency
Return on equity (ROE) is 13.94% and return on invested capital (ROIC) is 8.10%.
| Return on Equity (ROE) | 13.94% |
| Return on Assets (ROA) | 4.17% |
| Return on Invested Capital (ROIC) | 8.10% |
| Return on Capital Employed (ROCE) | 7.89% |
| Weighted Average Cost of Capital (WACC) | 4.51% |
| Revenue Per Employee | $255,118 |
| Profits Per Employee | $5,328 |
| Employee Count | 25,200 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 22.16 |
Taxes
In the past 12 months, Ardent Health has paid $57.09 million in taxes.
| Income Tax | 57.09M |
| Effective Tax Rate | 19.91% |
Stock Price Statistics
The stock price has increased by +1.31% in the last 52 weeks. The beta is 0.75, so Ardent Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +1.31% |
| 50-Day Moving Average | 9.76 |
| 200-Day Moving Average | 9.91 |
| Relative Strength Index (RSI) | 59.32 |
| Average Volume (20 Days) | 523,487 |
Short Selling Information
The latest short interest is 4.61 million, so 3.22% of the outstanding shares have been sold short.
| Short Interest | 4.61M |
| Short Previous Month | 3.63M |
| Short % of Shares Out | 3.22% |
| Short % of Float | 8.48% |
| Short Ratio (days to cover) | 7.85 |
Income Statement
In the last 12 months, Ardent Health had revenue of $6.43 billion and earned $134.28 million in profits. Earnings per share was $0.95.
| Revenue | 6.43B |
| Gross Profit | 3.77B |
| Operating Income | 339.41M |
| Pretax Income | 286.75M |
| Net Income | 134.28M |
| EBITDA | 501.89M |
| EBIT | 339.41M |
| Earnings Per Share (EPS) | $0.95 |
Balance Sheet
The company has $611.22 million in cash and $2.29 billion in debt, with a net cash position of -$1.68 billion or -$11.71 per share.
| Cash & Cash Equivalents | 611.22M |
| Total Debt | 2.29B |
| Net Cash | -1.68B |
| Net Cash Per Share | -$11.71 |
| Equity (Book Value) | 1.73B |
| Book Value Per Share | 9.34 |
| Working Capital | 1.07B |
Cash Flow
In the last 12 months, operating cash flow was $435.08 million and capital expenditures -$217.08 million, giving a free cash flow of $217.99 million.
| Operating Cash Flow | 435.08M |
| Capital Expenditures | -217.08M |
| Depreciation & Amortization | 162.49M |
| Net Borrowing | -3.35M |
| Free Cash Flow | 217.99M |
| FCF Per Share | $1.52 |
Margins
Gross margin is 58.60%, with operating and profit margins of 5.28% and 2.09%.
| Gross Margin | 58.60% |
| Operating Margin | 5.28% |
| Pretax Margin | 4.46% |
| Profit Margin | 2.09% |
| EBITDA Margin | 7.81% |
| EBIT Margin | 5.28% |
| FCF Margin | 3.39% |
Dividends & Yields
Ardent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.91% |
| Shareholder Yield | -3.91% |
| Earnings Yield | 8.57% |
| FCF Yield | 13.91% |
Analyst Forecast
The average price target for Ardent Health is $12.05, which is 10.75% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.05 |
| Price Target Difference | 10.75% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 3.56% |
| EPS Growth Forecast (3Y) | -5.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ardent Health has an Altman Z-Score of 2.11 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.11 |
| Piotroski F-Score | 7 |